ITOC5 Conference (2018)
In-Person Event
Mar 19 - 21, 2018
Berlin, Berlin, DE
OVERVIEW
5th Immunotherapy of Cancer Conference (ITOC5) is organized by Cancer Drug Development Forum (CDDF) and will be held during Mar 19 - 21, 2018 at Mercure Hotel MOA Berlin, Berlin, Germany.
Conference Description :
is the premier meeting for education, scientific exchange, and networking within the cancer immunotherapy field. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
Additional details will be posted as soon as they are available.
Conference Description :
is the premier meeting for education, scientific exchange, and networking within the cancer immunotherapy field. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
Additional details will be posted as soon as they are available.
KEY DATES
19 Mar, 2018
Event Start Date
21 Mar, 2018
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Mercure Hotel MOA BerlinRELATED CONFERENCES & LIVE WEBINARS
Quick Links